De Hert M - Search Results

1

Relationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophrenia.

Vancampfort D, Probst M, Scheewe T, De Herdt A, Sweers K, Knapen J, van Winkel R, De Hert M. Vancampfort D, et al. Among authors: de herdt a, de hert m. Psychiatry Res. 2013 May 15;207(1-2):25-32. doi: 10.1016/j.psychres.2012.09.026. Epub 2012 Oct 7. Psychiatry Res. 2013. PMID: 23051886

2

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.

De Hert MA, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J. De Hert MA, et al. Schizophr Res. 2006 Mar;83(1):87-93. doi: 10.1016/j.schres.2005.12.855. Epub 2006 Feb 14. Schizophr Res. 2006. PMID: 16481149 Free article.

3

Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: a 10-year follow-up study.

van Winkel R, Myin-Germeys I, Delespaul P, Peuskens J, De Hert M, van Os J. van Winkel R, et al. Among authors: de hert m. Schizophr Res. 2006 Dec;88(1-3):47-54. doi: 10.1016/j.schres.2006.06.033. Epub 2006 Aug 10. Schizophr Res. 2006. PMID: 16904292

4

A case series: evaluation of the metabolic safety of aripiprazole.

De Hert M, Hanssens L, van Winkel R, Wampers M, Van Eyck D, Scheen A, Peuskens J. De Hert M, et al. Schizophr Bull. 2007 May;33(3):823-30. doi: 10.1093/schbul/sbl037. Epub 2006 Aug 29. Schizophr Bull. 2007. PMID: 16940338 Free PMC article.

5

Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE.

De Hert M, Peuskens B, van Winkel R, Kalnicka D, Hanssens L, Van Eyck D, Wyckaert S, Peuskens J. De Hert M, et al. Schizophr Res. 2006 Dec;88(1-3):222-6. doi: 10.1016/j.schres.2006.07.025. Epub 2006 Sep 22. Schizophr Res. 2006. PMID: 16996250

6

Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods.

van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J. van Winkel R, et al. Among authors: de hert m. J Clin Psychiatry. 2006 Oct;67(10):1493-500. doi: 10.4088/jcp.v67n1002. J Clin Psychiatry. 2006. PMID: 17107239

7

Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia.

Hanssens L, De Hert M, Kalnicka D, van Winkel R, Wampers M, Van Eyck D, Scheen A, Peuskens J. Hanssens L, et al. Among authors: de hert m. Int Clin Psychopharmacol. 2007 Jan;22(1):43-9. doi: 10.1097/YIC.0b013e3280113d3b. Int Clin Psychopharmacol. 2007. PMID: 17159459

8

Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder.

De Hert M, Kalnicka D, van Winkel R, Wampers M, Hanssens L, Van Eyck D, Scheen A, Peuskens J. De Hert M, et al. J Clin Psychiatry. 2006 Dec;67(12):1889-96. doi: 10.4088/jcp.v67n1208. J Clin Psychiatry. 2006. PMID: 17194266

9

Remission criteria for schizophrenia: evaluation in a large naturalistic cohort.

De Hert M, van Winkel R, Wampers M, Kane J, van Os J, Peuskens J. De Hert M, et al. Schizophr Res. 2007 May;92(1-3):68-73. doi: 10.1016/j.schres.2007.01.010. Epub 2007 Mar 2. Schizophr Res. 2007. PMID: 17336500

10

Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.

Peuskens J, De Hert M, Mortimer A; SOLIANOL Study Group. Peuskens J, et al. Among authors: de hert m. Int Clin Psychopharmacol. 2007 May;22(3):145-52. doi: 10.1097/YIC.0b013e3280148c29. Int Clin Psychopharmacol. 2007. PMID: 17414740 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters